These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 29595506)
41. Comparison of the effectiveness of WHO short-course chemotherapy and standard Russian antituberculous regimens in Tomsk, western Siberia. Mawer C; Ignatenko N; Wares D; Strelis A; Golubchikova V; Yanova G; Lyagoshina T; Sharaburova O; Banatvala N Lancet; 2001 Aug; 358(9280):445-9. PubMed ID: 11513907 [TBL] [Abstract][Full Text] [Related]
42. [Tuberculosis--still increasing threat. Time for mobilization over the national borders]. Larsson LO Lakartidningen; 2009 Jul 22-Aug 4; 106(30-31):1882-3. PubMed ID: 19739439 [No Abstract] [Full Text] [Related]
43. [Weight loss, fatigue, night sweats--tuberculosis might be the reason]. Stiefelhagen P MMW Fortschr Med; 2009 Sep; 151(37):42, 44-5. PubMed ID: 19827427 [No Abstract] [Full Text] [Related]
44. Public health. Responding to market failures in tuberculosis control. Gupta R; Kim JY; Espinal MA; Caudron JM; Pecoul B; Farmer PE; Raviglione MC Science; 2001 Aug; 293(5532):1049-51. PubMed ID: 11463877 [No Abstract] [Full Text] [Related]
45. Emerging epidemic of drug-resistant tuberculosis in Europe, Russia, China, South America and Asia: current status and global perspectives. Migliori GB; Centis R; Lange C; Richardson MD; Sotgiu G Curr Opin Pulm Med; 2010 May; 16(3):171-9. PubMed ID: 20134324 [TBL] [Abstract][Full Text] [Related]
46. Drug-resistant tuberculosis: what is to be done? Schluger NW Chest; 2009 Aug; 136(2):333-335. PubMed ID: 19666753 [No Abstract] [Full Text] [Related]
47. Household screening and multidrug-resistant tuberculosis. Cox H; van Cutsem G Lancet; 2011 Jan; 377(9760):103-4. PubMed ID: 21145582 [No Abstract] [Full Text] [Related]
48. More cases of drug-resistant tuberculosis complicate care but spur global research and innovation. Wilson JF Ann Intern Med; 2009 Mar; 150(6):433-6. PubMed ID: 19293087 [No Abstract] [Full Text] [Related]
50. Changing the game for multidrug-resistant tuberculosis. Ghanashyam B Lancet; 2016 Mar; 387(10024):1149-50. PubMed ID: 27025324 [No Abstract] [Full Text] [Related]
51. [Drug-resistant pulmonary tuberculosis at the penitentiaries]. Kononets AS Probl Tuberk Bolezn Legk; 2008; (12):60-3. PubMed ID: 19227326 [TBL] [Abstract][Full Text] [Related]
52. Break through multidrug-resistant TB. Gribble EA; Williams A Nurse Pract; 2010 Mar; 35(3):14-22; quiz 22-3. PubMed ID: 20164730 [No Abstract] [Full Text] [Related]
53. XDR tuberculosis--implications for global public health. Raviglione MC; Smith IM N Engl J Med; 2007 Feb; 356(7):656-9. PubMed ID: 17301295 [No Abstract] [Full Text] [Related]
54. [High incidence and resistance rates in Eastern Europe. Is tuberculosis coming back?]. Hauer B MMW Fortschr Med; 2004 Jun; 146(25):14. PubMed ID: 15354877 [No Abstract] [Full Text] [Related]
55. Combating drug-resistant tuberculosis: the unexpected benefits of bedaquiline. Furin J; Diacon AH; Andries K Int J Tuberc Lung Dis; 2017 Jan; 21(1):4-5. PubMed ID: 28157457 [No Abstract] [Full Text] [Related]
56. Programmatic management of multidrug-resistant tuberculosis: models from three countries. Furin J; Bayona J; Becerra M; Farmer P; Golubkov A; Hurtado R; Joseph JK; Keshavjee S; Ponomarenko O; Rich M; Shin S Int J Tuberc Lung Dis; 2011 Oct; 15(10):1294-300. PubMed ID: 21669029 [TBL] [Abstract][Full Text] [Related]